Unique biorepository stores samples from Alberta COVID-19 patients for future research
On Jun. 5, 2020, the Alberta Precision Laboratories (APL) COVID-19 Biorepository was announced to ensure researchers have the…
Study identified potential approach to treat severe respiratory distress in patients with COVID-19
On Jun. 5, 2020, early data from a clinical study suggested that blocking the Bruton tyrosine kinase (BTK)…
The US Department of Defense established collaborative virus genetic sequencing capability for COVID-19
On Jun. 5, 2020, to jumpstart the Department of Defense’s (DoD) SARS-CoV-2 sequencing efforts, Armed Forces Health Surveillance…
Calquence showed promising clinical improvement in majority of 19 hospitalised COVID-19 patients
On Jun. 5, 2020, results were published in Science Immunology showed that Calquence (acalabrutinib), a Brutonﾒs tyrosine kinase…
The UK Global Vaccine Summit secured $74 billion in funding to support global vaccine supply and immunisation
On Jun. 5, 2020, the UK thelped secure $7.4 billion in funding to support global vaccine supply and…
ViralClear added St David’s HealthCare to phase II trial for broad-spectrum oral anti-viral COVID-19 candidate
On Jun. 5, 2020, BioSig Technologies and its subsidiary, ViralClear Pharma, announced it had expanded its patient enrollment…
HPV vaccine manufacturers commited to provide enough supply to immunise at least 84 million girls in Gavi countries
On Jun. 4, 2020, vaccine manufacturers MSD, GSK, Innovax, Serum Institute of India and Walvax pledged to ramp…
HPV vaccine manufacturers committed to immunise at least 84 million girls in Gavi countries
On Jun. 4, 2020, vaccine manufacturers MSD, GSK, Innovax, Serum Institute of India (SII) and Walvax pledged to…
The FDA approved antibiotic to treat hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia
On Jun. 4, 2020, the FDA approved Merck’s Recarbrio (a combination of imipenem-cilastatin and relebactam) to treat hospital-acquired…
WHO announced new funding for vaccines
On Jun. 4, 2020, the WHO announced new pledges that will enable Gavi to protect the next generation…
Introduction and spread of SARS-CoV-2 in the greater Boston area
On Jun. 4, 2020, data from the Broad Institute of MIT and Harvard, Massachusetts General Hospital, and the…
Successful detailed tracking of major plant disease’s global spread
On Jun. 4, 2020, Agricultural Research Service scientists and their Oregon State University collaborators announced they had developed…
iBio announced second COVID-19 vaccine program
On Jun. 4, 2020, iBio announced it had initiatied preclinical immunization studies for its second COVID-19 vaccine platform….
Virginia Tech researchers established a reverse genetics system to facilitate COVID-19 research
On Jun. 4, 2020, with funding from the Fralin Life Sciences Institute at Virginia Tech, researchers James Weger-Lucarelli…
Roche initiated initiates phase III clinical trial of Actemra/RoActemra plus remdesivir in hospitalised patients with severe COVID-19 pneumonia
On Jun. 4, 2020, Roche announced the initiation of a global phase III, randomised, double-blind, multicentre study (REMDACTA)…
NIH study ties stroke-related brain blood vessel abnormality to gut bacteria
On Jun. 3, 2020, in a nationwide study, NIH funded researchers found that the presence of abnormal bundles…
NIH reported early results show benefit of remdesivir for COVID-19
On Jun. 2, 2020, the NIH reported that early results showed that remdesivir benefited hospitalized patients with severe…
FDA cleared IND for iNKT Cells to treat COVID-19 patients
On Jun. 2, 2020, Agenus announced the FDA’s clearance of AgenTus’ IND application for an allogeneic iNKT therapy….
Pfizer established $500 million program to support continued biotechnology innovation
On Jun. 2, 2020, Pfizer announced the establishment of the Pfizer Breakthrough Growth Initiative, through which Pfizer will…
The USDA announced the first confirmed case of a dog in the US to test positive for SARS-CoV-2
On Jun. 2, 2020, the USDA announced the first confirmed case of SARS-CoV-2 (the virus that causes COVID-19)…
Albert Einstein College of Medicine awarded $1 million for COVID-19 research from the Price Family Foundation
On Jun. 2, 2020, Albert Einstein College of Medicine announced it had received a $1 million challenge grant…
Trevena announced collaboration with Imperial College London to evaluate TRV027 in COVID-19 patients
On Jun. 2, 2020, Trevena announced it had entered into a collaboration with Imperial College London to evaluate…
Resverlogix announced COVID-19 clinical trial program launch
On Jun. 1, 2020, Resverlogix announced that it is moving forward with a plan to further evaluate apabetaloneﾒs…
Cytiva and Entos Pharmaceuticals work together to accelerate development of COVID19 vaccines
On Jun. 1, 2020, Entos Pharmaceuticals announced a partnership with Cytiva, formerly part of GE Healthcare Life Sciences….
The US Dept of Defense launched effort to collect COVID-19 convalescent plasma
On Jun. 1, 2020, U.S. Dept. of Defense announced it had begun an effort to collect 8,000 donated…
New Ebola outbreak detected in northwest Democratic Republic of the Congo
On Jun. 1, 2020, the Government of the Democratic Republic of the Congo announced that a new outbreak…
The USDA announced transition to preventive plan for virulent Newcastle disease in California
On Jun. 1, 2020, the USDA announced it is transitioning its virulent Newcastle disease (vND) efforts in southern…
Eli Lilly began world’s first study of a potential COVID-19 antibody treatment in humans
On Jun. 1, 2020, Eli Lilly announced patients had been dosed in the world’s first study of a…
Proteostasis Therapeutics announced in vitro data for PTI-129 as potential treatment candidate for COVID-19
On Jun. 1, 2020, Proteostasis Therapeutics announced results from in vitro studies evaluating the use of PTI-129 as…
FDA issued Emergency Use Authorization for Impella RP as therapy for COVID-19 patients with right heart failure
On Jun. 1, 2020, the FDA issued an emergency use authorization (EUA) for Impella RP to include patients…